1,078 results on '"Kwan, Lorna"'
Search Results
2. Longitudinal Quality of Life in Low-Income Men in a State-Funded Prostate Cancer Treatment Program
- Author
-
Zavala, Mary Wassel, Miller, David C., Fink, Arlene, Litwin, Mark S., Maliski, Sally L., and Kwan, Lorna
- Published
- 2008
- Full Text
- View/download PDF
3. Approach to Lower Urinary Tract Reconstruction: A Survey of Adult and Pediatric Urologist Perspectives and Experiences
- Author
-
Lembrikova, Katerina, Aninwene, George, Christensen, Katherine L, Tandel, Megha, Kwan, Lorna, Gonzalez-Padilla, Daniel, Teoh, Jeremy, and Sturm, Renea
- Subjects
Pediatric ,Clinical Research ,Bioengineering ,Urologic Diseases - Abstract
IntroductionRobotic adoption has rapidly increased within urology. Initial uptake in adult urology has outpaced that seen in pediatric procedures. The aim of this study was to determine adult and pediatric urologist satisfaction with specific procedural steps in lower urinary tract reconstruction (LUTR) using an open versus robotic approach and define drivers and barriers to robotics adoption to inform device development relevant to current needs.MethodsA survey was distributed to practicing urologists. Questions assessed surgeon demographics, technology adoption, satisfaction with anastomotic steps in continent neobladder (CN) and augmentation cystoplasty (AC), and drivers/barriers influencing robotic use.ResultsOf 110 respondents, 49% practiced in academic institutions; 51% reported non-academic, private, or other. Specializations were pediatrics (36%), oncology/robotics (25%), or other (39%). Sixty-eight percent completed training in the past decade. In the past year, 55% completed only open CN or AC, 36% only robotic, and 9% both. Of those that performed robotic procedures, 5% used only an intra-corporeal approach, 85% used only extra-corporeal, and 10% used both. Surgeons who performed robotic LUTR alone expressed high satisfaction with all CN and AC procedural steps evaluated. Overall, of the anastomoses evaluated, urologists found urethrovesical anastomoses more satisfactory using a robotic versus open approach. Pediatric versus adult urologists were overall less satisfied with the robotic approach. In terms of robotic adoption, major drivers for CN were adoption by neighboring institutions, improved perioperative outcomes, and equivalent oncological outcomes; barriers were cost of robotic purchase and maintenance, surgeon support for robotics, and difficult learning curve. Major drivers for AC were adoption by neighboring institutions, decreased operative time, and equivalent oncological outcomes; barriers were increased operative time, cost, and minimal perceived benefit of extracorporeal procedures.ConclusionUrologic oncologists and surgeons performing robotic LUTR alone were highly satisfied with the robotic approach. Pediatric urologists reported lower overall satisfaction with robotic steps in LUTR, potentially corresponding with limitations of current robotic platforms for pediatric application and relative training exposure. Major drivers overall were competition and outcomes; major barriers were cost, operative time, and learning curve. Based on this select surgeon cohort recruited through targeted social media platforms, maximizing surgeon experience through training and innovations to reduce complication rates is anticipated to facilitate broader adoption of robotics in LUTR. Future studies that include a broad international distribution across the specialty may further pinpoint specified needs for adult versus pediatric specialists and drive targeted robotics platform development.
- Published
- 2023
4. Health-Related Quality-of-Life in Low-Income, Uninsured Men with Prostate Cancer
- Author
-
Krupski, Tracey L, Fink, Arlene, Kwan, Lorna, Maliski, Sally, Connor, Sarah E, Clerkin, Barbara, and Litwin, Mark S
- Published
- 2005
- Full Text
- View/download PDF
5. Cryotherapy for partial gland ablation of prostate cancer: Oncologic and safety outcomes
- Author
-
Aker, Mamdouh N, Brisbane, Wayne G, Kwan, Lorna, Gonzalez, Samantha, Priester, Alan M, Kinnaird, Adam, Delfin, Merdie K, Felker, Ely, Sisk, Anthony E, Kuppermann, David, and Marks, Leonard S
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Clinical Research ,Prostate Cancer ,Clinical Trials and Supportive Activities ,Urologic Diseases ,Cancer ,Aging ,Male ,Humans ,Prostate-Specific Antigen ,Prospective Studies ,Prostatic Neoplasms ,Cryotherapy ,Image-Guided Biopsy ,Magnetic Resonance Imaging ,Prostate cancer ,cryotherapy ,focal therapy ,Biochemistry and Cell Biology ,Oncology and carcinogenesis - Abstract
BackgroundPartial gland ablation (PGA) is a new option for treatment of prostate cancer (PCa). Cryotherapy, an early method of PGA, has had favorable evaluations, but few studies have employed a strict protocol using biopsy endpoints in men with clinically significant prostate cancer (csPCa).Methods143 men with unilateral csPCa were enrolled in a prospective, observational trial of outpatient PGA-cryotherapy. Treatment was a 2-cycle freeze of the affected prostate part. Participants were evaluated with MRI-guided biopsy (MRGB) at baseline and at 6 months and 18 months after treatment. Absence of csPCa upon MRGB was the primary endpoint; quality-of-life at baseline and at 6 months after treatment was assessed by EPIC-CP questionnaires in the domains of urinary and sexual function.ResultsOf the 143 participants, 136 (95%) completed MRGB at 6 months after treatment. In 103/136 (76%), the biopsy revealed no csPCa. Of the 103, 71 subsequently had an 18-month comprehensive biopsy; of the 71 with 18-month biopsies, 46 (65%) were found to have no csPCa. MRI lesions became undetectable in 96/130 (74%); declines in median serum PSA levels (6.9 to 2.5 ng/mL), PSA density (0.15 to 0.07), and prostate volume (42 to 34cc) were observed (all p
- Published
- 2023
6. Comprehension, utility, and preferences of prostate cancer survivors for visual timelines of patient-reported outcomes co-designed for limited graph literacy: meters and emojis over comics.
- Author
-
Snyder, Lauren, Phan, Daniel, Williams, Kristen, Piqueiras, Eduardo, Connor, Sarah, George, Sheba, Kwan, Lorna, Villatoro Chavez, Jefersson, Tandel, Megha, Frencher, Stanley, Gore, John, Hartzler, Andrea, and Litwin, Mark
- Subjects
consumer health information ,health education ,health literacy ,patient-reported outcome measure ,user-centered design ,Cancer Survivors ,Comprehension ,Gastrointestinal Stromal Tumors ,Health Literacy ,Humans ,Male ,Patient Reported Outcome Measures ,Prostate ,Prostatic Neoplasms ,Survivors - Abstract
OBJECTIVE: Visual timelines of patient-reported outcomes (PRO) can help prostate cancer survivors manage longitudinal data, compare with population averages, and consider future trajectories. PRO visualizations are most effective when designed with deliberate consideration of users. Yet, graph literacy is often overlooked as a design constraint, particularly when users with limited graph literacy are not engaged in their development. We conducted user testing to assess comprehension, utility, and preference of longitudinal PRO visualizations designed for prostate cancer survivors with limited literacy. MATERIALS AND METHODS: Building upon our prior work co-designing longitudinal PRO visualizations with survivors, we engaged 18 prostate cancer survivors in a user study to assess 4 prototypes: Meter, Words, Comic, and Emoji. During remote sessions, we collected data on prototype comprehension (gist and verbatim), utility, and preference. RESULTS: Participants were aged 61-77 (M = 69), of whom half were African American. The majority of participants had less than a college degree (95%), had inadequate health literacy (78%), and low graph literacy (89%). Among the 4 prototypes, Meter had the best gist comprehension and was preferred. Emoji was also preferred, had the highest verbatim comprehension, and highest rated utility, including helpfulness, confidence, and satisfaction. Meter and Words both rated mid-range for utility, and Words scored lower than Emoji and Meter for comprehension. Comic had the poorest comprehension, lowest utility, and was least preferred. DISCUSSION: Findings identify design considerations for PRO visualizations, contributing to the knowledge base for visualization best practices. We describe our process to meaningfully engage patients from diverse and hard-to-reach groups for remote user testing, an important endeavor for health equity in biomedical informatics. CONCLUSION: Graph literacy is an important design consideration for PRO visualizations. Biomedical informatics researchers should be intentional in understanding user needs by involving diverse and representative individuals during development.
- Published
- 2022
7. Delivery Timing and Associated Outcomes in Pregnancies With Maternal Congenital Heart Disease at Term
- Author
-
Mok, Thalia, Woods, Allison, Small, Adam, Canobbio, Mary M, Tandel, Megha D, Kwan, Lorna, Lluri, Gentian, Reardon, Leigh, Aboulhosn, Jamil, Lin, Jeannette, and Afshar, Yalda
- Subjects
Congenital Structural Anomalies ,Clinical Trials and Supportive Activities ,Cardiovascular ,Pediatric ,Infant Mortality ,Preterm ,Low Birth Weight and Health of the Newborn ,Heart Disease ,Clinical Research ,Perinatal Period - Conditions Originating in Perinatal Period ,Conditions Affecting the Embryonic and Fetal Periods ,Prevention ,Reproductive health and childbirth ,Good Health and Well Being ,Female ,Gestational Age ,Heart Defects ,Congenital ,Humans ,Infant ,Newborn ,Odds Ratio ,Parturition ,Pregnancy ,Retrospective Studies ,congenital heart disease ,delivery timing ,early-term birth ,maternal cardiac disease ,early‐term birth ,Cardiorespiratory Medicine and Haematology - Abstract
Background Current recommendations for delivery timing of pregnant persons with congenital heart disease (CHD) are based on expert opinion. Justification for early-term birth is based on the theoretical concern of increased cardiovascular stress. The objective was to evaluate whether early-term birth with maternal CHD is associated with lower adverse maternal or neonatal outcomes. Methods and Results This is a retrospective cohort study of pregnant persons with CHD who delivered a singleton after 37 0/7 weeks gestation at a quaternary care center with a multidisciplinary cardio-obstetrics care team between 2013 and 2021. Patients were categorized as early-term (37 0/7 to 38 6/7 weeks) or full-term (≥39 0/7) births and compared. Multivariable logistic regression was conducted to calculate the adjusted odds ratio for the primary outcomes. The primary outcomes were composite adverse cardiovascular, maternal obstetric, and adverse neonatal outcome. Of 110 pregnancies delivering at term, 55 delivered early-term and 55 delivered full-term. Development of adverse cardiovascular and maternal obstetric outcome was not significantly different by delivery timing. The rate of composite adverse neonatal outcomes was significantly higher in early-term births (36% versus 5%, P
- Published
- 2022
8. Identification of Preference “Phenotypes” in Men With Prostate Cancer
- Author
-
Saigal, Christopher, Hollenbeck, Brett, Penson, David, Williams, Kristen, Kwan, Lorna, Saucedo, Josemanuel, and Bergman, Jon
- Published
- 2024
- Full Text
- View/download PDF
9. Evaluation of prepectoral reconstruction surgical outcomes: Main operating room vs ambulatory surgery center
- Author
-
Anderson, Lexy, Fung, Kandace, Lee, Ju Young, Musavi, Leila, Alnaseri, Tahera, Demirjian, Maral, Kwan, Lorna, Crisera, Cristopher, Festekjian, Jaco, and DeLong, Michael
- Published
- 2024
- Full Text
- View/download PDF
10. Quality of life in low-income men after surgical castration for metastatic prostate cancer
- Author
-
Gaither, Thomas W, Kwan, Lorna, Villatoro, Jefersson, and Litwin, Mark S
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Aging ,Clinical Research ,Cancer ,Patient Safety ,Urologic Diseases ,Prostate Cancer ,Good Health and Well Being ,Androgen Antagonists ,Humans ,Male ,Orchiectomy ,Prospective Studies ,Prostatic Neoplasms ,Quality of Life ,Prostate cancer ,Androgen deprivation therapy ,Castration ,Quality of life ,Urology & Nephrology ,Clinical sciences ,Oncology and carcinogenesis - Abstract
ObjectiveTo compare health-related quality of life in men who underwent surgical vs. medical castration for metastatic prostate cancer.MethodsWe analyzed data from a prospective cohort of men enrolled in a statewide public health program that provides care for prostate cancer among low-income, uninsured men from 2001 to 2020. Outcome measures included the RAND SF-12 and the UCLA Prostate Cancer Index (PCI) at baseline and every 6 months. We used generalized estimating equations to assess the independent impact of surgical vs. medical castration on health-related quality of life.ResultsAmong men with metastatic prostate cancer, 27 underwent orchiectomy, and 274 underwent medical castration. Median cohort age at enrollment was 61.3 years (IQR 56-65); 239 (79%) men had less than a high school education. Average follow-up was 8 months (range 0-45) since study enrollment. Seventy percent of patients within the surgical castration group had their orchiectomy prior to study enrollment (median months since orchiectomy at study enrollment was 9 months, IQR 1-43). Similarly, 59% of patients within the medical castration group had begun ADT prior to study enrollment (median months since ADT initiation at study enrollment was 4 months, IQR 1-12). The majority (66%) had metastatic disease at diagnosis. The 2 groups did not differ in age, race/ethnicity, education, monthly income, baseline PSA, Gleason score, or percent metastatic at diagnosis. SF-12 domains did not differ between those who underwent surgical vs. medical castration (on average throughout follow-up, physical component difference -2.0, 95% CI -8.0-3.9 and mental component difference -1.0, 95% CI -5.4-+3.4). Patients treated with orchiectomy reported better urinary function than those who underwent medical castration (+16 point, 95%CI 5.3-26).ConclusionsSurgical castration did not negatively impact general or disease-specific quality of life. The finding of improved urination after orchiectomy merits further inquiry. This may inform urologists' discussion of surgical vs. medical options for men with castration-sensitive metastatic prostate cancer.
- Published
- 2022
11. Risk Factors for Measles Nonimmunity in Rubella-Immune Pregnant Patients
- Author
-
Kassir, Elias, Holliman, Kerry, Negi, Masaru, Duong, Hai-Lang, Tandel, Megha D, Kwan, Lorna, Lee, Gwendolyn, Silverman, Neil S, Rao, Rashmi R, and Han, Christina S
- Subjects
Infectious Diseases ,Rare Diseases ,Prevention ,Clinical Research ,Vaccine Related ,Emerging Infectious Diseases ,Good Health and Well Being ,measles ,rubella ,prenatal care ,vaccine ,MMR ,Clinical Sciences ,Paediatrics and Reproductive Medicine ,Obstetrics & Reproductive Medicine - Abstract
Objectives Measles immunity testing, unlike that for rubella, is not currently part of prenatal screening even though immunity to both is conferred by the measles-mumps-rubella (MMR) vaccine. Although endemic transmission of measles was declared eliminated in the United States in 2001, outbreaks have continued to occur. Given the risks associated with measles infection during pregnancy, we sought to identify risk factors for measles nonimmunity (MNI) in rubella-immune (RI) pregnant individuals.Methods We performed a retrospective observational cross-sectional study of patients receiving prenatal care and delivering at two university hospitals and a county hospital in Southern California from April 1, 2019 to February 1, 2021. Inclusion criteria were pregnant individuals ≥18 years old who had serological testing for rubella and measles during pregnancy. Demographic data were extracted from electronic medical records, including results of serological testing and chronic medical conditions. All subjects were rubella immune, and we compared measles-immune (MI) with MNI groups.Results In total, 1,813 RI individuals were identified, with 1,467 (81%) MI and 346 (19%) MNI individuals. Variables associated with an increased risk of MNI included having public health insurance (adjusted relative risk [aRR]: 1.56; 95% confidence interval [CI]: 1.24, 1.97) and Hispanic ethnicity (aRR: 1.37; 95% CI: 1.06, 1.78). Black race was associated with a decreased risk of MNI (aRR: 0.52; 95% CI: 0.29, 0.91). Birth year before 1989 demonstrated a trend toward increased risk of MNI, but this did not reach statistical significance (aRR 1.23; 95% CI: 1.00, 1.52). No differences were seen between the two groups for medical comorbidities.Conclusion Our study is the first to demonstrate risk factors for measles MNI in patients with documented rubella immunity. In the absence of universal measles serological screening recommendations, the risk factors identified could help guide clinicians in selective screening for those at risk of needing postpartum MMR vaccination.Key points· The rate of measles nonimmunity is higher than previously reported.. · Hispanic ethnicity and use of public insurance are risk factors for measles nonimmunity.. · The current recommendation for history-based screening for measles immunity is likely insufficient..
- Published
- 2022
12. Determination of Whole Blood Loss From Minimally Invasive Myomectomy Using a Standardized Formula: A Pilot Study
- Author
-
Gigg, Marisa, Goldrath, Kathryn, Havard, Alexandra, Nguyen, Anissa V., Kwan, Lorna, Parvataneni, Ram, Mehta, Sukrant, Chiang, Alexander, Rodriguez, Valentina, and Fahey, Jacqueline
- Published
- 2024
- Full Text
- View/download PDF
13. Magnetic Resonance Imaging-Guided Biopsy in Active Surveillance of Prostate Cancer
- Author
-
Kinnaird, Adam, Yerram, Nitin K, O’Connor, Luke, Brisbane, Wayne, Sharma, Vidit, Chuang, Ryan, Jayadevan, Rajiv, Ahdoot, Michael, Daneshvar, Michael, Priester, Alan, Delfin, Merdie, Tran, Elizabeth, Barsa, Danielle E, Sisk, Anthony, Reiter, Robert E, Felker, Ely, Raman, Steve, Kwan, Lorna, Choyke, Peter L, Merino, Maria J, Wood, Bradford J, Turkbey, Baris, Pinto, Peter A, and Marks, Leonard S
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Prostate Cancer ,Aging ,Cancer ,Urologic Diseases ,Clinical Research ,Biomedical Imaging ,Aged ,Follow-Up Studies ,Humans ,Image-Guided Biopsy ,Magnetic Resonance Imaging ,Male ,Middle Aged ,Neoplasm Grading ,Prospective Studies ,Prostatectomy ,Prostatic Neoplasms ,Risk Factors ,Watchful Waiting ,image-guided biopsy ,prostatic neoplasms ,observation ,magnetic resonance imaging - Abstract
PurposeThe underlying premise of prostate cancer active surveillance (AS) is that cancers likely to metastasize will be recognized and eliminated before cancer-related disease can ensue. Our study was designed to determine the prostate cancer upgrading rate when biopsy guided by magnetic resonance imaging (MRGBx) is used before entry and during AS.Materials and methodsThe cohort included 519 men with low- or intermediate-risk prostate cancer who enrolled in prospective studies (NCT00949819 and NCT00102544) between February 2008 and February 2020. Subjects were preliminarily diagnosed with Gleason Grade Group (GG) 1 cancer; AS began when subsequent MRGBx confirmed GG1 or GG2. Participants underwent confirmatory MRGBx (targeted and systematic) followed by surveillance MRGBx approximately every 12 to 24 months. The primary outcome was tumor upgrading to ≥GG3.ResultsUpgrading to ≥GG3 was found in 92 men after a median followup of 4.8 years (IQR 3.1-6.5) after confirmatory MRGBx. Upgrade-free probability after 5 years was 0.85 (95% CI 0.81-0.88). Cancer detected in a magnetic resonance imaging lesion at confirmatory MRGBx increased risk of subsequent upgrading during AS (HR 2.8; 95% CI 1.3-6.0), as did presence of GG2 (HR 2.9; 95% CI 1.1-8.2) In men who upgraded ≥GG3 during AS, upgrading was detected by targeted cores only in 27%, systematic cores only in 25% and both in 47%. In 63 men undergoing prostatectomy, upgrading from MRGBx was found in only 5 (8%).ConclusionsWhen AS begins and follows with MRGBx (targeted and systematic), upgrading rate (≥GG3) is greater when tumor is initially present within a magnetic resonance imaging lesion or when pathology is GG2 than when these features are absent.
- Published
- 2022
14. A prostate cancer risk calculator (PCRC-MRI): Use of clinical and magnetic resonance imaging data to predict biopsy outcome in North American men
- Author
-
Kinnaird, Adam, Brisbane, Wayne, Kwan, Lorna, Priester, Alan, Chuang, Ryan, Barsa, Danielle E, Delfin, Merdie, Sisk, Anthony, Margolis, Daniel, Felker, Ely, Hu, Jim, and Marks, Leonard S
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Prostate Cancer ,Cancer ,Prevention ,Clinical Research ,Biomedical Imaging ,Urologic Diseases ,Aging ,4.1 Discovery and preclinical testing of markers and technologies ,Detection ,screening and diagnosis ,4.2 Evaluation of markers and technologies ,Urology & Nephrology ,Clinical sciences ,Oncology and carcinogenesis - Abstract
IntroductionA functional tool to optimize patient selection for magnetic resonance imaging (MRI)-guided prostate biopsy (MRGB) is an unmet clinical need. We sought to develop a prostate cancer risk calculator (PCRC-MRI) that combines MRI and clinical characteristics to aid decision-making for MRGB in North American men.MethodsTwo prospective registries containing 2354 consecutive men undergoing MRGB (September 2009 to April 2019) were analyzed. Patients were randomized into five groups, with one group randomly assigned to be the validation cohort against the other four groups as the discovery cohort. The primary outcome was detection of clinically significant prostate cancer (csPCa) defined as Gleason grade group ≥2. Variables included age, ethnicity, digital rectal exam (DRE), prior biopsy, prostate-specific antigen (PSA), prostate volume, PSA density, and MRI score. Odds ratios (OR) were calculated from multivariate logistic regression comparing two models: one with clinical variables only (clinical) against a second combining clinical variables with MRI data (clinical+MRI).ResultscsPCa was present in 942 (40%) of the 2354 men available for study. The positive and negative predictive values for csPCa in the clinical+MRI model were 57% and 89%, respectively. The area under the curve of the clinical+MRI model was superior to the clinical model in discovery (0.843 vs. 0.707, p
- Published
- 2022
15. Impact of mastectomy flap necrosis on prepectoral reconstructive outcomes
- Author
-
Musavi, Leila, Bingham, Elijah G., Anderson, Lexy, Alnaseri, Tahera, Demirjian, Maral, Kwan, Lorna, Crisera, Christopher, Festekjian, Jaco, and DeLong, Michael R.
- Published
- 2024
- Full Text
- View/download PDF
16. Comparison of Pelvic Floor Physical Therapy Attendance Based on Referring Provider Specialty
- Author
-
Fullerton, Morgan E, Mwesigwa, Patricia J, Tandel, Megha D, Kwan, Lorna, Grisales, Tamara, and Tarnay, Christopher M
- Subjects
Reproductive Medicine ,Biomedical and Clinical Sciences ,Clinical Sciences ,Aging ,Clinical Research ,Health Services ,Contraception/Reproduction ,Aged ,Female ,Humans ,Medicare ,Pelvic Floor ,Pelvic Floor Disorders ,Physical Therapy Modalities ,Pregnancy ,Retrospective Studies ,United States ,pelvic floor disorders ,conservative therapy ,pelvic floor physical therapy ,treatment adherence ,Clinical sciences ,Reproductive medicine - Abstract
ObjectiveThe objective of this study was to determine whether pelvic floor physical therapy (PFPT) attendance differs based on referring provider specialty and identify factors related to PFPT initiation and completion.MethodsThis was an institutional review board-approved retrospective cohort study examining referrals from female pelvic medicine and reconstructive surgery (FPMRS) and non-FPMRS providers at a single academic medical center to affiliated PFPT clinics over a 12-month period. Demographics, referring specialty and diagnoses, prior treatment, and details regarding PFPT attendance were collected. Characteristics between FPMRS and non-FPMRS referrals were compared and multivariate logistic regression analyses were performed to identify factors associated with PFPT initiation and completion.ResultsA total of 497 referrals were placed for PFPT. Compared with non-FPMRS referrals, FPMRS referrals were for patients who were older (54.7 years vs 35.6 years), and had higher parity; more were postmenopausal (56% vs 18%) and had Medicare insurance (22% vs 10%) (all P < 0.001). Most FPMRS referrals were for patients with urinary incontinence (69% vs 31%), whereas non-FPMRS referrals were for patients with pelvic pain (70% vs 27%) (both P < 0.0001). Pelvic floor physical therapy attendance was similar in both groups when comparing rates of initiation (47% vs 45%) and completion (13% vs 16%). In multivariate analysis, factors associated with initiation were age 65 years or older, additional therapy provided at referring visit, private insurance, Asian race, pregnant or postpartum at time of referral, and more than 1 referring diagnosis (all P < 0.05). No factors were associated with completion.ConclusionsLess than half of the patients referred to PFPT initiate therapy, and only 15% complete PFPT. The populations referred by FPMRS and non-FPMRS providers are different, but ultimately PFPT utilization is similar.
- Published
- 2022
17. Impact of Gabapentin on Postoperative Hypotension in Enhanced Recovery after Surgery Protocols for Microvascular Breast Reconstruction
- Author
-
Muetterties, Corbin E., Taylor, Jeremiah M., Kaeding, Diana E., Rosales Morales, Ricardo, Nguyen, Anissa V., Kwan, Lorna, Tseng, Charles Y., Delong, Michael R., and Festekjian, Jaco H.
- Published
- 2024
- Full Text
- View/download PDF
18. Multi‐Institutional Practice‐Patterns in Fetal Congenital Heart Disease Following Implementation of a Standardized Clinical Assessment and Management Plan
- Author
-
Afshar, Yalda, Hogan, Whitnee J, Conturie, Charlotte, Sunderji, Sherzana, Duffy, Jennifer Y, Peyvandi, Shabnam, Boe, Nina M, Melber, Dora, Fajardo, Viviana M, Tandel, Megha D, Holliman, Kerry, Kwan, Lorna, Satou, Gary, and Moon‐Grady, Anita J
- Subjects
Clinical Research ,Cardiovascular ,Prevention ,Perinatal Period - Conditions Originating in Perinatal Period ,Pediatric ,Heart Disease ,Conditions Affecting the Embryonic and Fetal Periods ,Reproductive health and childbirth ,Good Health and Well Being ,Adult ,California ,Cesarean Section ,Delivery ,Obstetric ,Female ,Gestational Age ,Heart Defects ,Congenital ,Humans ,Infant ,Newborn ,Maternal Age ,Patient Care Planning ,Practice Patterns ,Physicians' ,Pregnancy ,Pregnancy Outcome ,Prenatal Care ,Prenatal Diagnosis ,Quality Improvement ,Risk Adjustment ,cesarean ,fetal CHD ,obstetrics ,prenatal congenital heart disease ,SCAMP ,Cardiorespiratory Medicine and Haematology - Abstract
Background Prenatal diagnosis of congenital heart disease has been associated with early-term delivery and cesarean delivery (CD). We implemented a multi-institutional standardized clinical assessment and management plan (SCAMP) through the University of California Fetal-Maternal Consortium. Our objective was to decrease early-term (37-39 weeks) delivery and CD in pregnancies complicated by fetal congenital heart disease using a SCAMP methodology to improve practice in a high-risk and clinically complex setting. Methods and Results University of California Fetal-Maternal Consortium site-specific management decisions were queried following SCAMP implementation. This contemporary intervention group was compared with a University of California Fetal-Maternal Consortium historical cohort. Primary outcomes were early-term delivery and CD. A total of 496 maternal-fetal dyads with prenatally diagnosed congenital heart disease were identified, 185 and 311 in the historical and intervention cohorts, respectively. Recommendation for later delivery resulted in a later gestational age at delivery (38.9 versus 38.1 weeks, P=0.01). After adjusting for maternal age and site, historical controls were more likely to have a CD (odds ratio [OR],1.8; 95% CI, 2.1-2.8; P=0.004) and more likely (OR, 2.1; 95% CI, 1.4-3.3) to have an early-term delivery than the intervention group. Vaginal delivery was recommended in 77% of the cohort, resulting in 61% vaginal deliveries versus 50% in the control cohort (P=0.03). Among pregnancies with major cardiac lesions (n=373), vaginal birth increased from 51% to 64% (P=0.008) and deliveries ≥39 weeks increased from 33% to 48% (P=0.004). Conclusions Implementation of a SCAMP decreased the rate of early-term deliveries and CD for prenatal congenital heart disease. Development of clinical pathways may help standardize care, decrease maternal risk secondary to CD, improve neonatal outcomes, and reduce healthcare costs.
- Published
- 2021
19. Aneuploidy rates and likelihood of obtaining a usable embryo for transfer among in vitro fertilization cycles using preimplantation genetic testing for monogenic disorders and aneuploidy compared with in vitro fertilization cycles using preimplantation genetic testing for aneuploidy alone
- Author
-
Martel, Rachel A., Lee, Mabel B., Schadwell, Alessia, Siavoshi, Mehrnaz, Kwan, Lorna, Miller, Jenna, Leonard, Chelsea, Roman, Robert A., Armstrong, Abigail, and Kroener, Lindsay
- Published
- 2024
- Full Text
- View/download PDF
20. Establishing a global quality of care benchmark report
- Author
-
Sampurno, Fanny, Cally, Justin, Opie, Jacinta L, Kannan, Ashwini, Millar, Jeremy L, Finelli, Antonio, Vickers, Andrew J, Moore, Caroline M, Kowalski, Christoph, Foster, Claire, Barocas, Dan A, Galvin, David, Van Basten, Jean-Paul, Gore, John L, Ferencz, Julia, Lawson, Keith A, Ghani, Khurshid R, Kwan, Lorna, Saarela, Olli, Connor, Sarah E, Dieng, Sebastian, Linsell, Susan, Soeterik, Timo FW, Villanti, Paul, Litwin, Mark S, and Evans, Sue M
- Subjects
Health Services and Systems ,Health Sciences ,Generic health relevance ,Benchmarking ,Delivery of Health Care ,Humans ,Male ,Quality Indicators ,Health Care ,Registries ,Surveys and Questionnaires ,international registry ,benchmarking ,data display ,data science ,quality indicators ,R Markdown ,Information Systems ,Library and Information Studies ,Medical Informatics ,Health services and systems ,Applied computing - Abstract
BackgroundThe Movember funded TrueNTH Global Registry (TNGR) aims to improve care by collecting and analysing a consistent dataset to identify variation in disease management, benchmark care delivery in accordance with best practice guidelines and provide this information to those in a position to enact change. We discuss considerations of designing and implementing a quality of care report for TNGR.MethodsEleven working group sessions were held prior to and as reports were being built with representation from clinicians, data managers and investigators contributing to TNGR. The aim of the meetings was to understand current data display approaches, share literature review findings and ideas for innovative approaches. Preferred displays were evaluated with two surveys (survey 1: 5 clinicians and 5 non-clinicians, 83% response rate; survey 2: 17 clinicians and 18 non-clinicians, 93% response rate).ResultsConsensus on dashboard design and three data-display preferences were achieved. The dashboard comprised two performance summary charts; one summarising site's relative quality indicator (QI) performance and another to summarise data quality. Binary outcome QIs were presented as funnel plots. Patient-reported outcome measures of function score and the extent to which men were bothered by their symptoms were presented in bubble plots. Time series graphs were seen as providing important information to supplement funnel and bubble plots. R Markdown was selected as the software program principally because of its excellent analytic and graph display capacity, open source licensing model and the large global community sharing program code enhancements.ConclusionsInternational collaboration in creating and maintaining clinical quality registries has allowed benchmarking of process and outcome measures on a large scale. A registry report system was developed with stakeholder engagement to produce dynamic reports that provide user-specific feedback to 132 participating sites across 13 countries.
- Published
- 2021
21. The nature of embryonic mosaicism across female age spectrum: an analysis of 21,345 preimplantation genetic testing for aneuploidy cycles
- Author
-
Armstrong, Abigail, Kroener, Lindsay, Miller, Jenna, Nguyen, Anissa, Kwan, Lorna, and Quinn, Molly
- Published
- 2023
- Full Text
- View/download PDF
22. Enhanced Recovery after Surgery Protocol Decreases Length of Stay and Postoperative Narcotic Use in Microvascular Breast Reconstruction
- Author
-
Muetterties, Corbin E., Taylor, Jeremiah M., Kaeding, Diana E., Morales, Ricardo R., Nguyen, Anissa V., Kwan, Lorna, Tseng, Charles Y., Delong, Michael R., and Festekjian, Jaco H.
- Published
- 2023
- Full Text
- View/download PDF
23. Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potential
- Author
-
Miller, Eric T, You, Sungyong, Cadaneanu, Radu M, Kim, Minhyung, Yoon, Junhee, Liu, Sandy T, Li, Xinmin, Kwan, Lorna, Hodge, Jennelle, Quist, Michael J, Grasso, Catherine S, Lewis, Michael S, Knudsen, Beatrice S, Freeman, Michael R, and Garraway, Isla P
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Prostate Cancer ,Aging ,Cancer ,Human Genome ,Clinical Research ,Urologic Diseases ,Genetics ,Detection ,screening and diagnosis ,4.1 Discovery and preclinical testing of markers and technologies ,Good Health and Well Being ,Aged ,Aged ,80 and over ,Aneuploidy ,Biomarkers ,Tumor ,Biopsy ,Needle ,Chromosomal Instability ,Databases ,Genetic ,Disease Progression ,Gene Expression Profiling ,Gene Expression Regulation ,Neoplastic ,Humans ,Male ,Middle Aged ,Neoplasm Metastasis ,Neoplasm Staging ,Prognosis ,Prostatic Neoplasms ,Sequence Analysis ,RNA ,Survival Rate ,Prostate cancer ,Metastases ,Chromosomal instability ,CIN ,Prostate needle biopsies ,TCGA ,Public Health and Health Services ,Oncology & Carcinogenesis ,Oncology and carcinogenesis ,Epidemiology - Abstract
BackgroundMetastatic prostate cancer (PC) is highly lethal. The ability to identify primary tumors capable of dissemination is an unmet need in the quest to understand lethal biology and improve patient outcomes. Previous studies have linked chromosomal instability (CIN), which generates aneuploidy following chromosomal missegregation during mitosis, to PC progression. Evidence of CIN includes broad copy number alterations (CNAs) spanning > 300 base pairs of DNA, which may also be measured via RNA expression signatures associated with CNA frequency. Signatures of CIN in metastatic PC, however, have not been interrogated or well defined. We examined a published 70-gene CIN signature (CIN70) in untreated and castration-resistant prostate cancer (CRPC) cohorts from The Cancer Genome Atlas (TCGA) and previously published reports. We also performed transcriptome and CNA analysis in a unique cohort of untreated primary tumors collected from diagnostic prostate needle biopsies (PNBX) of localized (M0) and metastatic (M1) cases to determine if CIN was linked to clinical stage and outcome.MethodsPNBX were collected from 99 patients treated in the VA Greater Los Angeles (GLA-VA) Healthcare System between 2000 and 2016. Total RNA was extracted from high-grade cancer areas in PNBX cores, followed by RNA sequencing and/or copy number analysis using OncoScan. Multivariate logistic regression analyses permitted calculation of odds ratios for CIN status (high versus low) in an expanded GLA-VA PNBX cohort (n = 121).ResultsThe CIN70 signature was significantly enriched in primary tumors and CRPC metastases from M1 PC cases. An intersection of gene signatures comprised of differentially expressed genes (DEGs) generated through comparison of M1 versus M0 PNBX and primary CRPC tumors versus metastases revealed a 157-gene "metastasis" signature that was further distilled to 7-genes (PC-CIN) regulating centrosomes, chromosomal segregation, and mitotic spindle assembly. High PC-CIN scores correlated with CRPC, PC-death and all-cause mortality in the expanded GLA-VA PNBX cohort. Interestingly, approximately 1/3 of M1 PNBX cases exhibited low CIN, illuminating differential pathways of lethal PC progression.ConclusionsMeasuring CIN in PNBX by transcriptome profiling is feasible, and the PC-CIN signature may identify patients with a high risk of lethal progression at the time of diagnosis.
- Published
- 2020
24. 21 Code of Federal Regulations Part 11-Compliant Digital Signature Solution for Cancer Clinical Trials: A Single-Institution Feasibility Study.
- Author
-
Miller, Therica M, Lester, Jenny, Kwan, Lorna, Tandel, Megha D, Karlan, Beth Y, and Rimel, BJ
- Subjects
Health Services and Systems ,Health Sciences ,Cancer ,Clinical Research ,Clinical Trials and Supportive Activities ,Feasibility Studies ,Humans ,Neoplasms ,Pilot Projects ,Prospective Studies ,Surveys and Questionnaires - Abstract
PurposeInefficiencies in the clinical trial infrastructure result in protracted trial completion timelines, physician-investigator turnover, and a shrinking skilled labor force and present obstacles to research participation. Taken together, these barriers hinder scientific progress. Technological solutions to improve clinical trial efficiency have emerged, yet adoption remains slow because of concerns with cost, regulatory compliance, and implementation.MethodsA prospective pilot study that compared regulatory-compliant digital and traditional wet ink paper signatures was conducted over a 6.5-month period in a hospital-based health system. Staff time and effort, error rate, costs, and time to completion were measured. Wilcoxon rank sum tests were used to compare staff time and time to completion. A value analysis was conducted. A survey was administered to measure user satisfaction.ResultsThere where 96 participants (47 digital, 49 paper), 132 studies included (31 digital, 101 paper), and 265 documents processed (156 digital, 109 paper). A moderate reduction in staff time required to prepare documents for signature was observed (P < .0001). Error rates were reported in 5.1% of digital and 2.8% of paper documents, but this difference was not significant. Discrepancies requiring revisions included incomplete mandatory fields, inaccurate information submitted, and technical issues. A value analysis demonstrated a 19% labor savings with the use of digital signatures. Survey response rate was 57.4% (n = 27). Most participants (85.2%) preferred digital signatures. The time to complete documents was faster with digital signatures compared with paper (P = .0241).ConclusionThe use of digital signatures resulted in a decrease in document completion time and regulatory burden as represented by staff hours. Additional cost and time savings and information liquidity could be realized by integrating digital signatures and electronic document management systems.
- Published
- 2020
25. Prenatal Congenital Heart Disease and Placental Phenotypes: Preserved Neonatal Weight Despite Small Placentas
- Author
-
Desmond, Angela, Imany-Shakibai, Helia, Wong, Deanna, Kwan, Lorna, Satou, Gary, Sklansky, Mark, and Afshar, Yalda
- Published
- 2023
- Full Text
- View/download PDF
26. Novel Use of a Social-Media-Based Survey to Detect Regional Differences in Management of Monochorionic-Diamniotic Twins.
- Author
-
Pluym, Ilina D, Paek, Bettina, Walker, Martin, Liu, Hui, Kwan, Lorna, Rao, Rashmi, Scibetta, Emily, Afshar, Yalda, Holliman, Kerry, Wong, Thalia, Platt, Lawrence D, and Han, Christina S
- Subjects
Humans ,Fetofetal Transfusion ,Cross-Sectional Studies ,Perinatology ,Pregnancy ,Internationality ,Adolescent ,Adult ,Middle Aged ,Guideline Adherence ,Female ,Young Adult ,Pregnancy ,Twin ,Social Media ,Surveys and Questionnaires ,Clinical Research ,Behavioral and Social Science ,Pediatric ,Good Health and Well Being ,Facebook ,monochorionic diamniotic ,social media ,survey ,web-based research ,twins ,Clinical Sciences ,Paediatrics and Reproductive Medicine ,Obstetrics & Reproductive Medicine - Abstract
ObjectiveThis study aims to evaluate the utility of social media to distribute a patient survey on differences in management and outcomes of monochorionic-diamniotic (MCDA) pregnancies.Study designA cross-sectional survey was posted to an English-language MCDA twins patient-centered support group within the social media site, Facebook from April 2, 2018 to June 26, 2018. Subjects were recruited through a technique called "snowballing," whereby individuals shared the survey to assist with recruiting. Patient reported data were analyzed using Chi-square and Kruskal-Wallis's tests to explore characteristics associated with surveillance and outcomes as related to region and provider type.ResultsOver 3 months, the post "reached" 14,288 Facebook users, among which 5,653 (40%) clicked on the post. A total of 2,357 respondents with MCDA pregnancies completed the survey. Total 1,928 (82%) were from the United States (US) and 419 (18%) from other countries. Total 85% of patients had co-management with maternal-fetal medicine (MFM), more in the US compared with the rest of the world (87 vs. 74%, p
- Published
- 2020
27. Early recurrence of Focal Segmental Glomerulosclerosis in kidney transplant recipients: When to consider regifting
- Author
-
Wood, Erika L., Kwan, Lorna, Burrows, Julia E., Singh, Gurbir, Veale, Jeffrey, and Lum, Erik L
- Published
- 2023
- Full Text
- View/download PDF
28. Prophylactic Unfractionated Heparin in Antepartum Hospitalizations
- Author
-
Mok, Thalia, primary, Nguyen, Anissa V., additional, Kwan, Lorna, additional, Steinberg, Irving, additional, Vallera, Cristianna, additional, Silverman, Neil S., additional, and Rao, Rashmi, additional
- Published
- 2024
- Full Text
- View/download PDF
29. PD29-04 ASSOCIATION OF AGENT ORANGE EXPOSURE AND PROSTATE CANCER INCIDENCE AND METASTASIS AMONG VIETNAM VETERANS DIAGNOSED AND TREATED IN THE VETERANS HEALTH ADMINISTRATION
- Author
-
Green-Lott, Ashley-Marie, primary, Wadhwa, Ananta, additional, Nguyen, Anissa V., additional, Kwan, Lorna, additional, Haroldsen, Candace L., additional, Shelton, Jeremy B., additional, Chamie, Karim, additional, Schoen, Martin, additional, Rettig, Matthew, additional, Maxwell, Kara N., additional, and Garraway, Isla P., additional
- Published
- 2024
- Full Text
- View/download PDF
30. PD43-12 A NON-INFERIORITY TRIAL FOR TELEMEDICINE IN THE MANAGEMENT OF OVERACTIVE BLADDER
- Author
-
Weinberger, James M., primary, Gu, Cindy, additional, Romeo, Hannah, additional, Cabri, John, additional, Kwan, Lorna, additional, Siavoshi, Mehrnaz, additional, and Nitti, Victor W., additional
- Published
- 2024
- Full Text
- View/download PDF
31. MP25-02 METRICS OF TREATMENT OUTCOME FOLLOWING PARTIAL GLAND ABLATION FOR PROSTATE CANCER: PSA, MRI, OR BIOPSY?
- Author
-
Brisbane, Wayne, primary, Richardson, Shannon, additional, Kinnaird, Adam, additional, Kwan, Lorna, additional, Gonzalez, Samantha, additional, Priester, Alan M., additional, Felker, Ely R., additional, Sisk, Anthony E., additional, Delfin, Merdie, additional, and Marks, Leonard S., additional
- Published
- 2024
- Full Text
- View/download PDF
32. MP68-19 CHARACTERISTICS AND OUTCOMES OF PRIMARY NEUROENDOCRINE/SMALL CELL PROSTATE CANCER OCCURRING IN THE VETERAN AFFAIRS (VA) POPULATION
- Author
-
Nwonwu, Chelsea K. N., primary, Raychaudhuri, Ruben, additional, Wadhu, Anata, additional, Green-Lott, Ashley-Marie Y., additional, Kwan, Lorna, additional, Haroldsen, Candace L., additional, Effiong, Atim, additional, Shelton, Jeremy B., additional, Knudsen, Beatrice S., additional, Rettig, Mattew B., additional, Nickols, Nicholas G., additional, Maxwell, Kara N., additional, Montgomery, Robert B., additional, and Garraway, Isla P., additional
- Published
- 2024
- Full Text
- View/download PDF
33. PD26-09 IMPACT OF FOCAL THERAPY ON DEFERRAL OF SURGERY OR RADIATION DURING ACTIVE SURVEILLANCE OF PROSTATE CANCER
- Author
-
Richardson, Shannon, primary, Gonzalez, Samantha, additional, Kwan, Lorna, additional, Delfin, Merdie, additional, Nguyen, Anissa V., additional, Rodriguez, Sara, additional, Brisbane, Wayne, additional, and Marks, Leonard S., additional
- Published
- 2024
- Full Text
- View/download PDF
34. PD50-04 CAN PSMA-TARGETED PROSTATE BIOPSY DETECT CANCER WHEN MRI-GUIDED BIOPSY IS NEGATIVE?
- Author
-
Brisbane, Wayne G., primary, Topoozian, Mark T., additional, Calais, Jeremie, additional, Delfin, Merdie K., additional, Kwan, Lorna, additional, Gonzalez, Samantha R., additional, and Marks, Leonard S., additional
- Published
- 2024
- Full Text
- View/download PDF
35. 15. Breast Implant Illness: Making Sense Of The Symptoms
- Author
-
Luvisa, Brendon K., primary, Demirjian, Maral, additional, Kwan, Lorna, additional, and DeLong, Michael R., additional
- Published
- 2024
- Full Text
- View/download PDF
36. Do contemporary imaging and biopsy techniques reliably identify unilateral prostate cancer? Implications for hemiablation patient selection.
- Author
-
Johnson, David, Yang, Jason, Kwan, Lorna, Barsa, Danielle, Mirak, Sohrab, Pooli, Aydin, Sadun, Taylor, Jayadevan, Rajiv, Zhou, Steve, Priester, Alan, Natarajan, Shyam, Bajgiran, Amirhossein, Shakeri, Sepideh, Sisk, Anthony, Felker, Ely, Raman, Steven, Marks, Leonard, and Reiter, Robert
- Subjects
focal therapy ,hemiablation ,magnetic resonance imaging ,patient selection ,prostatectomy ,prostatic neoplasms ,unilateral ,Humans ,Image-Guided Biopsy ,Male ,Middle Aged ,Patient Selection ,Prostatic Neoplasms ,Retrospective Studies ,Ultrasound ,High-Intensity Focused ,Transrectal - Abstract
BACKGROUND: Hemiablation is a less morbid treatment alternative for appropriately selected patients with unilateral prostate cancer (PCa). However, to the authors knowledge, traditional diagnostic techniques inadequately identify appropriate candidates. In the current study, the authors quantified the accuracy for identifying hemiablation candidates using contemporary diagnostic techniques, including multiparametric magnetic resonance imaging (mpMRI) and MRI-fusion with complete systematic template biopsy. METHODS: A retrospective analysis of patients undergoing MRI and MRI-fusion prostate biopsy, including full systematic template biopsy, prior to radical prostatectomy in a single tertiary academic institution between June 2010 and February 2018 was performed. Hemiablation candidates had unilateral intermediate-risk PCa (Gleason score [GS] of 3+4 or 4+3, clinical T classification ≤T2, and prostate-specific antigen level
- Published
- 2019
37. Cancer core length from targeted biopsy: an index of prostate cancer volume and pathological stage
- Author
-
Simopoulos, Demetrios N, Sisk, Anthony E, Priester, Alan, Felker, Ely R, Kwan, Lorna, Delfin, Merdie K, Reiter, Robert E, and Marks, Leonard S
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Prostate Cancer ,Clinical Research ,Biomedical Imaging ,Cancer ,Urologic Diseases ,4.1 Discovery and preclinical testing of markers and technologies ,Aged ,Humans ,Image-Guided Biopsy ,Magnetic Resonance Imaging ,Male ,Middle Aged ,Neoplasm Grading ,Neoplasm Staging ,Prostatectomy ,Prostatic Neoplasms ,Retrospective Studies ,Tumor Burden ,Ultrasonography ,Interventional ,magnetic resonance imaging ,tumour volume ,#ProstateCancer ,#PCSM ,Urology & Nephrology ,Clinical sciences ,Oncology and carcinogenesis - Abstract
ObjectiveTo study the relationship of maximum cancer core length (MCCL), on targeted biopsy (TB) of magnetic resonance imaging (MRI)-visible index lesions, to volume of that tumour found at radical prostatectomy (RP).Patients and methodsIn all, 205 men undergoing fusion biopsy and RP were divided into two groups: 136 in whom the MCCL came from an index MRI-visible lesion (TB) and 69 in whom MCCL came from a non-targeted lesion (non-targeted biopsy [NTB]). MRI was 3-T multi-parametric and biopsy was via MRI-ultrasonography fusion.ResultsIn the TB group, MCCL correlated with volume of clinically significant index tumours (ρ = 0.44-0.60, P 10 mm) and MRI lesion diameter (>20 mm) were independently associated with tumour volume. TB MCCLs >10 mm and Gleason scores >7 were each associated with pathological T3 disease (odds ratios 5.73 and 5.04, respectively), but MRI lesion diameter lesion was not.ConclusionsMCCL on a TB from an MRI-visible lesion is an independent predictor of both cancer volume and pathological stage. This relationship does not exist for MCCL from a NTB core. Quantifying CCL on MRI-TBs may have a value, not previously described, to risk-stratify patients with prostate cancer before treatment.
- Published
- 2019
38. Utility of Restriction Spectrum Imaging Among Men Undergoing First-Time Biopsy for Suspected Prostate Cancer.
- Author
-
Felker, Ely R, Raman, Steven S, Shakeri, Sepideh, Mirak, Sohrab A, Bajgiran, Amirhossein M, Kwan, Lorna, Khoshnoodi, Pooria, ElKhoury, Fuad F, Margolis, Daniel JA, Karow, David, Lu, David SK, White, Nate, and Marks, Leonard S
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Clinical Research ,Cancer ,Biomedical Imaging ,Aging ,Prostate Cancer ,Urologic Diseases ,4.2 Evaluation of markers and technologies ,Detection ,screening and diagnosis ,Aged ,Aged ,80 and over ,Contrast Media ,Diffusion Magnetic Resonance Imaging ,Humans ,Image-Guided Biopsy ,Male ,Middle Aged ,Multimodal Imaging ,Prospective Studies ,Prostatic Neoplasms ,Retrospective Studies ,Ultrasonography ,biopsy ,DWI ,prostate cancer ,Nuclear Medicine & Medical Imaging ,Clinical sciences - Abstract
OBJECTIVE. The purpose of this article is to evaluate restriction spectrum imaging (RSI) in men undergoing MRI-ultrasound fusion biopsy for suspected prostate cancer (PCa) and to compare the performance of RSI with that of conventional DWI. MATERIALS AND METHODS. One hundred ninety-eight biopsy-naïve men enrolled in a concurrent prospective clinical trial evaluating MRI-targeted prostate biopsy underwent multiparametric MRI with RSI. Clinical and imaging features were compared between men with and without clinically significant (CS) PCa (MRI-ultrasound fusion biopsy Gleason score ≥ 3 + 4). RSI z score and apparent diffusion coefficient (ADC) were correlated, and their diagnostic performances were compared. RESULTS. CS PCa was detected in 109 of 198 men (55%). Using predefined thresholds of ADC less than or equal to 1000 μm2/s and RSI z score greater than or equal to 3, sensitivity and specificity for CS PCa were 86% and 38%, respectively, for ADC and 61% and 70%, respectively, for RSI. In the transition zone (n = 69), the sensitivity and specificity were 94% and 17%, respectively, for ADC and 59% and 69%, respectively, for RSI. Among lesions with CS PCa, RSI z score and ADC were significantly inversely correlated in the peripheral zone (ρ = -0.4852; p < 0.01) but not the transition zone (ρ = -0.2412; p = 0.17). Overall diagnostic accuracies of RSI and DWI were 0.70 and 0.68, respectively (p = 0.74). CONCLUSION. RSI and DWI achieved equivalent diagnostic performance for PCa detection in a large population of men undergoing first-time prostate biopsy for suspected PCa, but RSI had superior specificity for transition zone lesions.
- Published
- 2019
39. Use of MRI-Guided Biopsy for Selection and Follow-up of Men Undergoing Hemi-gland Cryoablation of Prostate Cancer
- Author
-
Zhou, Steve R, Simopoulos, Demetrios N, Jayadevan, Rajiv, Felker, Ely R, Delfin, Merdie K, Barsa, Danielle E, Kwan, Lorna, and Marks, Leonard S
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Clinical Research ,Biomedical Imaging ,Cancer ,Aging ,Urologic Diseases ,Prostate Cancer ,Aged ,Cryosurgery ,Follow-Up Studies ,Humans ,Image-Guided Biopsy ,Magnetic Resonance Imaging ,Male ,Patient Selection ,Prospective Studies ,Prostatic Neoplasms ,Quality of Life ,Treatment Outcome ,Urology & Nephrology ,Clinical sciences - Abstract
ObjectiveTo investigate safety, efficacy, and quality of life impact of hemi-gland cryotherapy for clinically-significant prostate cancer (CaP), when patient selection and follow-up includes MRI-guided biopsy.MethodsTwenty-nine men with unilateral CaP (all clinically significant with prostate volume
- Published
- 2019
40. Clinical outcomes and complications of recipients of HLA matched living donor kidney transplants at UCLA: A retrospective chart review
- Author
-
Wood, Erika L., Kogut, Neil, Kwan, Lorna, Burrows, Julia, Veale, Jeffrey, and Lum, Erik L
- Published
- 2022
- Full Text
- View/download PDF
41. Targeted Prostate Biopsy: Umbra, Penumbra, and Value of Perilesional Sampling
- Author
-
Brisbane, Wayne G., Priester, Alan M., Ballon, Jorge, Kwan, Lorna, Delfin, Merdie K., Felker, Ely R., Sisk, Anthony E., Hu, Jim C., and Marks, Leonard S.
- Published
- 2022
- Full Text
- View/download PDF
42. Favorable Simplified Bishop Score after cervical ripening associated with decreased cesarean birth rate
- Author
-
Lee, Daniel S., Tandel, Megha D., Kwan, Lorna, Francoeur, Alex A., Duong, Hai-Lang, and Negi, Masaru
- Published
- 2022
- Full Text
- View/download PDF
43. Spirituality and religiosity of non‐directed (altruistic) living kidney donors
- Author
-
Maghen, Ariella, Vargas, Grecia B, Connor, Sarah E, Nassiri, Sima, Hicks, Elisabeth M, Kwan, Lorna, Waterman, Amy D, Maliski, Sally L, and Veale, Jeffrey L
- Subjects
Nursing ,Health Sciences ,Clinical Research ,Organ Transplantation ,Kidney Disease ,Transplantation ,Adult ,Aged ,Aged ,80 and over ,Altruism ,Christianity ,Decision Making ,Female ,Humans ,Kidney Transplantation ,Living Donors ,Male ,Middle Aged ,Motivation ,Qualitative Research ,Spirituality ,United States ,beliefs ,decision-making ,grounded theory ,health services research ,qualitative study ,transplantation ,Public Health and Health Services ,Psychology ,Health services and systems - Abstract
Aims and objectivesTo describe the spirituality and religiosity of 30 non-directed (altruistic) living kidney donors in the USA and explore how they may have affected their motivations to donate and donation process experiences.BackgroundThe rise in non-directed donors and their ability to initiate kidney chains offer a novel approach to help alleviate the overextended kidney transplant wait list in the USA. However, little is known about the non-directed donors' motivations, characteristics and experiences.DesignWe conducted a qualitative-dominant study and used a grounded theory approach to analyse data.MethodsThirty participants completed in-depth interviews between April 2013-April 2015. Three analysts independently read and coded interview transcripts. Grounded theory techniques were used to develop descriptive categories and identify topics related to the non-directed donors donation experience.ResultsSixteen of the 30 non-directed donorss discussed the topic of spirituality and religiosity when describing their donation experiences, regardless of whether they were actively practising a religion at the time of donation. Specifically, three themes were identified within spirituality and religiosity: motivation to donate, support in the process, and justification of their donation decisions postdonation.ConclusionsFindings from this study are the first to describe how spirituality and religiosity influenced the experiences of U.S. non-directed donorss and may help improve non-directed donors educational resources for future spiritual or religious non-directed donors, and the overall non-directed donors donation experience in efforts to increase the living donor pool.Relevance to clinical practiceSpirituality and religiosity are often overlooked yet potentially influential factors in Western medicine, as demonstrated through the experiences of Jehovah's Witnesses and their religious restrictions while undergoing surgery and the beliefs of Christian Scientists against taking medications and receiving medical procedures. Understanding needs of non-directed donors specifically with spirituality and religiosity can better position kidney transplant centres and teams to improve predonation screening of non-directed donor candidates and provide support services during the donation process.
- Published
- 2018
44. Shipping living donor kidneys and transplant recipient outcomes
- Author
-
Treat, Eric, Chow, Eric KH, Peipert, John D, Waterman, Amy, Kwan, Lorna, Massie, Allan B, Thomas, Alvin G, Bowring, Mary Grace, Leeser, David, Flechner, Stuart, Melcher, Marc L, Kapur, Sandip, Segev, Dorry L, and Veale, Jeffrey
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Clinical Research ,Transplantation ,Kidney Disease ,Organ Transplantation ,Renal and urogenital ,Adult ,Cold Ischemia ,Delayed Graft Function ,Female ,Follow-Up Studies ,Glomerular Filtration Rate ,Graft Rejection ,Graft Survival ,Humans ,Kidney Failure ,Chronic ,Kidney Function Tests ,Kidney Transplantation ,Living Donors ,Male ,Middle Aged ,Organ Preservation ,Prognosis ,Risk Factors ,Survival Rate ,Time Factors ,Tissue and Organ Harvesting ,Tissue and Organ Procurement ,Transplant Recipients ,Travel ,clinical research ,practice ,delayed graft function ,donors and donation: paired exchange ,graft survival ,health services and outcomes research ,kidney transplantation ,nephrology ,clinical research/practice ,kidney transplantation/nephrology ,Medical and Health Sciences ,Surgery ,Clinical sciences ,Immunology - Abstract
Kidney paired donation (KPD) is an important tool to facilitate living donor kidney transplantation (LDKT). Concerns remain over prolonged cold ischemia times (CIT) associated with shipping kidneys long distances through KPD. We examined the association between CIT and delayed graft function (DGF), allograft survival, and patient survival for 1267 shipped and 205 nonshipped/internal KPD LDKTs facilitated by the National Kidney Registry in the United States from 2008 to 2015, compared to 4800 unrelated, nonshipped, non-KPD LDKTs. Shipped KPD recipients had a median CIT of 9.3 hours (range = 0.25-23.9 hours), compared to 1.0 hour for internal KPD transplants and 0.93 hours for non-KPD LDKTs. Each hour of CIT was associated with a 5% increased odds of DGF (adjusted odds ratio: 1.05, 95% confidence interval [CI], 1.02-1.09, P .9). This study of KPD-facilitated LDKTs found no evidence that long CIT is a concern for reduced graft or patient survival. Studies with longer follow-up are needed to refine our understanding of the safety of shipping donor kidneys through KPD.
- Published
- 2018
45. IMMUNOTHERAPY UTILIZATION PATTERNS IN METASTATIC BLADDER CANCER: ASSESSING INSURANCE STATUS AS A MODIFIABLE FACTOR ASSOCIATED WITH FAILURE TO RECEIVE NOVEL THERAPIES
- Author
-
Zhang, JJ H., primary, Lin, Lin, additional, Kwan, Lorna, additional, Starr, Savannah L., additional, Shen, Jolie Z., additional, Blumberg, Jeremy M., additional, Gollapudi, Kiran, additional, Drakaki, Alexandra, additional, Chamie, Karim, additional, and Gamalong, Giovanni M., additional
- Published
- 2024
- Full Text
- View/download PDF
46. Impact of Mastectomy Flap Necrosis on Pre-Pectoral Reconstructive Outcomes
- Author
-
Musavi, Leila, primary, Bingham, Elijah G., additional, Anderson, Lexy, additional, Alnaseri, Tahera, additional, Demirjian, Maral, additional, Kwan, Lorna, additional, Crisera, Christopher, additional, Festekjian, Jaco, additional, and DeLong, Michael R., additional
- Published
- 2024
- Full Text
- View/download PDF
47. Randomized control trial of postpartum visits at 2 and 6 weeks
- Author
-
Pluym, Ilina D., Tandel, Megha D., Kwan, Lorna, Mok, Thalia, Holliman, Kerry, Afshar, Yalda, and Rao, Rashmi
- Published
- 2021
- Full Text
- View/download PDF
48. Health Care Disparities Among Latina Patients Presenting With Pelvic Organ Prolapse
- Author
-
Douglass, K. Marie, Grisales, Tamara, Coca, Natalie, Tandel, Megha D., Kwan, Lorna, and Wieslander, Cecilia
- Published
- 2022
- Full Text
- View/download PDF
49. Quality of Life after Laparoscopic and Open Abdominal Myomectomy
- Author
-
Rodriguez-Triana, Valentina M., Kwan, Lorna, Kelly, Mikaela, Olson, Tara H., and Parker, William H.
- Published
- 2021
- Full Text
- View/download PDF
50. Impact of treatment on progression to castration‐resistance, metastases, and death in men with localized high‐grade prostate cancer
- Author
-
Miller, Eric T, Chamie, Karim, Kwan, Lorna, Lewis, Michael S, Knudsen, Beatrice S, and Garraway, Isla P
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Aging ,Patient Safety ,Clinical Research ,Urologic Diseases ,Cancer ,Prostate Cancer ,Good Health and Well Being ,Adult ,Aged ,Aged ,80 and over ,Androgen Antagonists ,Disease Progression ,Humans ,Incidence ,Male ,Middle Aged ,Neoplasm Grading ,Neoplasm Metastasis ,Prostatectomy ,Prostatic Neoplasms ,Prostatic Neoplasms ,Castration-Resistant ,Radiotherapy ,Risk Factors ,Survival Analysis ,Treatment Outcome ,ADT ,disease progression ,HGPC ,risk ,ADT ,HGPC ,Biochemistry and Cell Biology ,Oncology and carcinogenesis - Abstract
Men with high-grade prostate cancer (HGPC) are at greatest risk of disease progression. Clinical risk factors associated with castration-resistant prostate cancer (CRPC), metastases, and prostate cancer-specific mortality (PCSM) were identified in a contemporary HGPC cohort. Clinical data was collected from men diagnosed with Gleason sum (GS) ≥8 at the Greater Los Angeles Veterans Affairs (GLA-VA) Healthcare System between 2000 and 2013. Multivariable competing risks regression analyses assessed progression to CRPC, metastases, and PCSM within three treatment strata. The cumulative incidence of disease progression was calculated at 2, 5, and 10-year time points. Review of 2149 prostate cancer cases yielded 322 with HGPC. Median survival times for cancer-specific and overall mortality were significantly shorter in men treated with primary androgen deprivation therapy (ADT) (P = 0.0002 and P
- Published
- 2017
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.